NCT02503865View on ClinicalTrials.gov

Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

351

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2014

Conditions

Metabolic Syndrome

Interventions

DRUG

Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin

Xenical (Orlistat) - 120 mg/day in integration of Pionorm (Pioglitazone hydrochlorid) - 30 mg/day, Diroton (Lizinopril) - 20 mg/day, Diltiazem - 90 mg/day, Atorvastatin (Liprimar) - 40 mg/day

DIETARY_SUPPLEMENT

"Analimentary detoxication"

Vegetable and salt diet

Trial Locations (1)

010000

Republican Scientific Center for Emergency Medicine, Astana

All Listed Sponsors

collaborator

Institute Of Cardiology & Internal Diseases, Kazakhstan

OTHER_GOV

lead

Nazarbayev University

OTHER

NCT02503865 - Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome | Biotech Hunter | Biotech Hunter